{"id":323,"date":"2014-06-25T22:47:59","date_gmt":"2014-06-25T20:47:59","guid":{"rendered":"http:\/\/beta.oegpb.at\/?page_id=323"},"modified":"2021-05-13T05:15:06","modified_gmt":"2021-05-13T03:15:06","slug":"forschung-2011","status":"publish","type":"page","link":"https:\/\/oegpb.at\/?page_id=323","title":{"rendered":"Forschung 2011"},"content":{"rendered":"

[et_pb_section fb_built=“1″ _builder_version=“4.9.4″ _module_preset=“a101c382-f6f4-4378-9eee-5c6c65b689e1″ locked=“off“][et_pb_row _builder_version=“4.9.3″ _module_preset=“default“ custom_padding=“||10px||false|false“][et_pb_column type=“4_4″ _builder_version=“4.9.3″ _module_preset=“default“][et_pb_post_title _builder_version=“4.9.3″ _module_preset=“7fd05a31-4b65-4680-8d87-3be606eca9dc“][\/et_pb_post_title][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=“1″ admin_label=“section“ _builder_version=“3.22″][et_pb_row admin_label=“row“ _builder_version=“4.9.4″ background_size=“initial“ background_position=“top_left“ background_repeat=“repeat“ box_shadow_style=“preset1″ custom_padding=“40px|40px|40px|40px|true|true“ custom_padding_last_edited=“on|phone“ hover_enabled=“0″ sticky_enabled=“0″ custom_padding_phone=“|20px||20px|true|true“][et_pb_column type=“4_4″ _builder_version=“3.25″ custom_padding=“|||“ custom_padding__hover=“|||“][et_pb_text admin_label=“Text“ _builder_version=“3.27.4″ background_size=“initial“ background_position=“top_left“ background_repeat=“repeat“]<\/p>\n

Ausgew\u00e4hlte Publikationen f\u00fcr das Jahr 2011<\/h2>\n

Aktuelle Forschungsarbeiten der Klinischen Abteilung f\u00fcr Biologische Psychiatrie, Universit\u00e4tsklinik f\u00fcr Psychiatrie und Psychotherapie, Wien, Abteilungsvorstand:<\/strong>
O. Univ. Prof. Dr.h.c.mult. Dr.med. Siegfried Kasper:
sci-biolpsy@meduniwien.ac.at<\/a><\/p>\n

<\/a>Publikationen 2011<\/h2>\n

Abbate Daga G, Gramaglia C, Bailer U, Bergese S, Marzola E, Fassino S (2011) Major Depression and Avoidant Personality Traits in Eating Disorders. Psychotherapy and<\/em><\/a> Psychosomatics<\/em><\/a> 80 (5): 319-320 (IF: 6.000)<\/p>\n

Acel A, Jank R, Schranz S, Zielinski C (2011) Klinische Psychologie in der Inneren Medizin I \u2013 Klinisch psychologische Betreuung von ambulanten und station\u00e4ren PatientInnen bei malignen Erkrankungen. In: Lehrner J, Stolba K, Traun-Vogt G, V\u00f6lkl-Kernstock S (Hrsg.) Klinische<\/a> Psychologie im Krankenhaus<\/a>. Wien: Springer, pp. 203-211<\/p>\n

Aigner M, Treasure J, Kaye W, Kasper S and the WFSBP task force on eating disorders (2011) The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of eating disorders. World Journal of Biological Psychiatry<\/em> 12 (6):<\/a> 400-443 <\/a>(IF: 2.048)<\/p>\n

Aschauer H (2011) Genetik und Epigenetik. In: L\u00f6ffler-Stastka H., Schuster P, und Doering S. (Hrsg.) Psychische Funktionen in Gesundheit und Krankheit.<\/a> 8., vollst. \u00fcberarb. Auflage. Wien: Facultas, pp 74-93<\/p>\n

Baghai TC, Blier P, Baldwin DS, Bauer M, Goodwin GM, Fountoulakis KN, Kasper S, Leonard BE, Malt UF, Stein DJ, Versiani M, M\u00f6ller HJ for the World Psychiatric Association (WPA) section of pharmacopsychiatry (2011) General and comparative efficacy and effectiveness of antidepressants in the acute treatment of depressive disorders: a report by the WPA section of pharmacopsychiatry. European Archives of Psychiatry and Clinical Neuroscience<\/em> 261 (Suppl.<\/a> 3): 207-245<\/a> (IF: 3.637)<\/p>\n

Bailer UF, Bloss CS, Frank GK, Price JC, Meltzer CC, Mathis CA, Geyer MA, Wagner A, Becker CR, Schork NJ, Kaye WH (2011) 5-HT1A receptor binding is increased after recovery from bulimia nervosa compared to control women and is associated with behavioral inhibition in both groups. International Journal of Eating Disorders<\/em><\/a> 44 (6): 477- 487 (IF: 2.278)<\/p>\n

Bailer UF, Kaye WH (2011) Serotonin \u2013 imaging findings in eating disorders. Current Topics in<\/em><\/a> Behavioral Neurosciences<\/em><\/a> 6: 59-79 (IF: 0)<\/p>\n

Bauer S, Schanda H, Karakula H, Olajossy-Hilkesberger L, Rudaleviciene P, Okribelashvili N, Chaudhry H, Idemudia S, Gscheider S, Ritter K, Stompe T (2011) Culture and the prevalence of hallucinations in schizophrenia. Comprehensive Psychiatry<\/em><\/a> 52 (3): 319-325 (IF: 2.377)<\/p>\n

Bauer SM, Steiner H, Feucht M, Stompe T, Karnik NS, Kasper S, Plattner B (2011) Psychosocial background in incarcerated adolescents from Austria, Turkey and former Yugoslavia. Psychiatry Research<\/em><\/a> 185 (1-2): 193-199 ( IF: 2.803)<\/p>\n

Bokkon I, Till A, Grass F, Erd\u00f6fi Szabo A (2011) Phantom pain reduction by low-frequency and low-intensity electromagnetic fields. Electromagnetic Biology and Medicine<\/em><\/a> 30 (3): 115-27 (IF:
1.041)<\/p>\n

Bruckm\u00fcller K, K\u00f6chl B, Fischer G, Jagsch R, Soyer R (2011) Medizinische und juristische Beurteilung substanzabh\u00e4ngiger (mutma\u00dflicher) T\u00e4ter. Journal f\u00fcr Rechtspolitik<\/em><\/a> 19 (3): 267-278
(IF: 0)<\/p>\n

Cath DC, Hedderly T, Ludolph AG, Stern JS, Murphy T, Hartmann A, Czernecki V, Robertson MM, Martino D, Munchau A, Rizzo R on behalf of the ESSTS Guidelines Group (Androutsos C, Aschauer H, Baird G, Bos-Veneman N, Bramilla A, Cardona F, Cath DC, Cavanna A, Czernecki V, Dehing S, Eapter A, Farkas L, Gadaros J, Hartmann A, Hauser E, Hedderly T, Heyman I, Hoekstra PJ, Korsgaard A, Jackson GM, Larsson L, Ludolph AG, Martino D, Menghetti C, Mol Debes N, Muller N, Muller-Vahl K, Munchau A, Murphy T, Musil R, Nagy P, Nurnberger J, Oostra B, Paschou P, Pasquini M, Plessen KJ, Porta M, Rickards H, Rizzo R, Robertson MM, Roessner V, Rothenberger A, Servello D, Skov L, Stern JS, Strand G, Tarnok Z, Termine C, Van der Griendt J, Verdellen C, Visser Vanderwalle V, Wannag E, Wolanczyck T) (2011) European clinical guidelines for Tourette Syndrome and other tic disorders. Part I: assessment. European<\/em> Child & Adolescent Psychiatry<\/em><\/a> 20 (7): 155-171 (IF: 1.622)<\/p>\n

Diaconescu AO, Jensen J, Wang H, Willeit M, Menon M, Kapur S, McIntosh AR (2011)
Aberrant Effective Connectivity in Schizophrenia Patients During Appetitive Conditioning.
Frontiers in Human Neuroscience<\/em><\/a> 4: 239 (IF: 1.940)<\/p>\n

Dold M, Aigner M, Lanzenberger R, Kasper S (2011) Effektivit\u00e4t einer Augmentationstherapie mit Antipsychotika bei therapieresistenten Zwangsst\u00f6rungen – eine Meta-Analyse doppelblinder,
randomisierter, plazebokontrollierter Studien. Fortschritte Neurologie Psychiatrie<\/em><\/a> 79 (8): 453- 466 (IF: 0.652)<\/p>\n

Fink M, Moser U, Akimova E, Savli M, Lanzenberger R, Kasper S (2011) Multimodale Bildgebung bei einer organischen depressiven St\u00f6rung mittels fMRT und PET. Journal f\u00fcr Neurologie, Neurochirurgie und Psychiatrie<\/em><\/a> 12 (2): 180-182 (IF: 0)<\/p>\n

Fischer G (2011) Gerechtigkeit \u2013 Gl\u00fcck\/Gl\u00fccksspiel \u2013 Pathologisches Gl\u00fccksspiel. Sucht<\/em><\/a> 57 (4): 1-2 (IF: 0)<\/p>\n

Fischer P, Winkler D (2011) Demenz aus Sicht der Psychiatrie. In: Maier M, H\u00f6rhan J (Hrsg). Arzt\/\u00c4rztin & Ethik<\/em>. 5. Auflage. Wien: Facultas, pp. 282-287<\/p>\n

Fischer-Kern M, Kapusta N, Doering S, Hoerz S, Mikutta C, Aigner M (2011) The Relationship between Personality Organization and Psychiatric Classification in Chronic Pain Patients. Psychopathology<\/em><\/a> 44 (1): 21-26 (IF: 1.819)<\/p>\n

Frey R, Winkler D, Strnad A, Kasper S (2011) An der Schnittstelle zur Organmedizin.
Psychiatrische Intensivstation. CliniCum neuropsy<\/em><\/a> 3: 20-23 (IF: 0)<\/p>\n

Friedrich ME, Kasper S (2011) Das metabolische Syndrom – Stellenwert in der Psychiatrie. CliniCum neuropsy<\/a> 1<\/em>: 14-16 (IF: 0)<\/p>\n

Hahn A, Stein P, Windischberger C, Weissenbacher A, Spindelegger C, Moser E, Kasper S, Lanzenberger R (2011) Reduced resting-state functional connectivity between amygdala and
orbitofrontal cortex in social anxiety disorder. NeuroImage<\/em><\/a> 56 (3): 881-889 (IF: 5.937)<\/p>\n

Heil S, Jones H, Arria A, Kaltenbach K, Thomas J, Fischer G, Stine S, Selby P, Martin P (2011)
Unintended pregnancy in opioid-abusing women. Journal of Substance Abuse Treatment<\/a><\/em> 40 (2):
199-202 (IF: 2.805)<\/p>\n

H\u00f6fer P, Syeda B, Bergler-Klein J, Friedrich F, Lesch O, Vyssoki B, Binder T, Walter H (2011) Amino-Terminal Pro-B-Type Brain Natriuretic Peptide: Screening for Cardiovascular Disease in the Setting of Alcoholism. Alcohol and Alcoholism<\/em><\/a> 46 (3): 247- 252 (IF: 2.599)<\/p>\n

Holzer D, Stompe T (2011) Mord und Totschlag – Zusammenhang zwischen T\u00f6tungsdelikten und Kultur. \u00c4rzte Woche<\/a> 3: 11-12 (IF: 0)<\/p>\n

Holzer D, Stompe T (2011) Transkulturelle Psychiatrie: Pr\u00e4valenz psychischer Erkrankungen bei Migranten. <\/em>Spectrum Psychiatrie<\/em><\/a> 1: 39-42 (IF: 0)<\/p>\n

Huf W, Kalcher K, Kasper S (2011) Widespread methodological problems limit validity of
metaanalytic results. Psychotherapy and Psychosomatics<\/em><\/a> 80 (4): 246 (IF: 6.000)<\/p>\n

Huf W, Kalcher K, Pail G, Friedrich ME, Filzmoser P, Kasper S (2011) Metaanalysis: fact or fiction? How to interpret metaanalyses. World Journal of Biological Psychiatry<\/em><\/a> 12 (3): 188-200
(IF: 2.048)<\/p>\n

Inada Y, Nagata T, Kasper S (2011) \u30d1\u30cd\u30eb\u30c7\u30a3\u30b9\u30ab\u30c3\u30b7\u30e7\u30f3 (Proceedings of paneldiscussion). Published in Japanese language. CNS Drugs<\/em> 25 (Special Issue 1): 14-16 (IF:
4.497)<\/p>\n

Kapusta N, Aschauer H (2011) Psychopharmakotherapie. In: L\u00f6ffler-Stastka H., Schuster P, und
Doering S. (Hrsg.) Psychische Funktionen in Gesundheit und Krankheit<\/em>. 8., vollst. \u00fcberarb.
Auflage. Wien: Facultas, pp 306-311<\/p>\n

Kapusta N, Mossaheb N, Etzersdorfer E, Hlavin G, Thau K, Willeit M, Praschak-Rieder N, Sonneck G, Leithner-Dziubas K (2011) Lithium in drinking water and suicide mortality. British<\/em> Journal of Psychiatry<\/em><\/a> 198 (5): 346-350 (IF: 5.947)<\/p>\n

Kasper S (2011) Die verschiedenen Facetten des Ansprechens auf einen antidepressive Therapie und deren praktische Bedeutung. Journal f\u00fcr Neurologie, Neurochirurgie und Psychiatrie<\/em><\/a> 12 (2): 116-117 (IF: 0)<\/p>\n

Kasper S (2011) From single depressive episode to depressive disorder: what are the risk factors? Medicographia<\/em><\/a> 33 (2): 187-194 (IF: 0)<\/p>\n

Kasper S (2011) Kann man Gef\u00fchle sichtbar machen? Die Seele weint mit dem Gehirn. In: van Heyster P, Klammer B, Pycha R, Schwitzer J (Hrsg.) Die verborgene Kraft des Glaubens<\/em>.
Brixen: Provinz Verlag<\/a>, pp. 27-31<\/p>\n

Kasper S (2011) Prof. Dr. med. Dr. h.c. mult. Hans-J\u00fcrgen M\u00f6ller in der Medizin. Medizin +<\/em> Kunst<\/em> 23 (4): 8-12 (IF: 0)<\/p>\n

Kasper S (2011) Psychiatrie \u2013 quo vadis? CliniCum neuropsy<\/em><\/a> 5: 6-8 (IF: 0)<\/p>\n

Kasper S (2011) Unipolare Depression. CiniCum neuropsy<\/em><\/a> 5: 26-28 (IF: 0)<\/p>\n

Kasper S (2011) \u6297\u3046\u3064\u85ac\u3092\u7528\u3044\u305f\u500b\u3005\u306e\u60a3\u8005\u306b\u5bfe\u3059\u308b\u6cbb\u7642: SSRI\/SNRI \u304a\u3088\u3073\u30df\u30eb\u30bf\u30b6 \u30d4\u30f3\u306b\u3064\u3044\u3066 (Individualized patient treatment with anti- depressants: focus on SSRIs\/SNRIs and mirtazapine). Published in Japanese language. CNS Drugs<\/em> 25 (Special Issue 1): 10-13 (IF:
4.497)<\/p>\n

Kasper S, Bach M, Fartacek R, Fruhw\u00fcrth G, Haring C, Hausmann A, Kapfhammer HP, Marksteiner J, Psota G, Rados C, Stupp\u00e4ck C (2011) Experten-Statement: Therapeutisches Spektrum von Duloxetin mit Schwerpunkt Major Depression – ein Update. (Update Europe<\/a>)
Internationale Zeitschrift f\u00fcr \u00e4rztliche Fortbildung<\/em> 15 (ISSN 1726-0027) (IF: 0)<\/p>\n

Kasper S, Bach M, Hausmann A, Hofmann P, Konstantinidis A, Lentner S, Psota G, Rainer M, Schosser-Haupt A, Spindelegger C, Wrobel M, Frey R, Geretsegger C, Haring C, Jelem H, Kapfhammer HP, Claudia Klier, Marksteiner J, Oberlerchner H, Praschak-Rieder N, Rados C, Windhager E, Winkler D (2011) Therapieresistente Depression. Klinik und Behandlungsoptionen. Konsensus-Statement – State of the art 2011<\/a>. CliniCum neuropsy<\/em>
Sonderausgabe November 2011 (IF: 0)<\/p>\n

Kasper S, Baghai TC, Padberg F (2011) Sonstige biologische Therapieverfahren – Theoretische und empirische Grundlagen sowie klinische Anwendungsprinzipien. In: M\u00f6ller HJ, Laux G, Kapfhammer HP (Hrsg.) Psychiatrie und Psychotherapie<\/em><\/a>. 4. Auflage. Heidelberg: Springer, pp.
767-805<\/p>\n

Kasper S, Baldinger P, H\u00f6flich A, Lanzenberger R (2011) Die unipolare Depression richtig erkennen. Rasche Hilfe durch neue Therapieoptionen. Hausarzt<\/em> 7-8: 6-8 (IF: 0)<\/p>\n

Kasper S, Gastpar M, M\u00fcller WE, Volz HP, M\u00f6ller HJ, Dienel A, Schl\u00e4fke S (2011)
Wirksamkeit und Vertr\u00e4glichkeit von Silexan, einer neuen, oral verabreichten Zubereitung aus Lavendel\u00f6l, bei subsyndromaler Angstst\u00f6rung – Evidenz aus klinischen Pr\u00fcfungen. Zeitschrift<\/em><\/a>
f\u00fcr Phytotherapie<\/em><\/a> 32: 60-63 (IF: 0)<\/p>\n

Kasper S, Haring C (2011) Ratgeber f\u00fcr Depression und Angstst\u00f6rungen (Patientenbrosch\u00fcre).
(Update Europe) Internationale Zeitschrift f\u00fcr \u00c4rztliche Fortbildung<\/em>, pp. 1-18 (IF: 0)<\/p>\n

Kasper S, Kalousek M, Kapfhammer HP, Aichhorn W, Butterfield-Meissl C, Fartacek R, Frey R, G\u00f6\u00dfler R, Haring C, Kapitany T, Kapusta N, Karwautz A, Klier C, Konstantinidis A, Leuteritz I, Marksteiner J, Musalek M, Niederkrotenthaler T, Praschak-Rieder N, Psota G, Rados C, Rainer M, Stein C, T\u00f6lk A, Wancata J, Windhager E (2011) Suizidalit\u00e4t. Konsensus-Statement – State of the art 2011. CliniCum neuropsy<\/em> Sonderausgabe<\/a> April 2011 (IF:0)<\/p>\n

Kasper S, Kapfhammer HP, Bach M, Erfurth A, Haring C, Hausmann A, Hofmann P, Jelem H, Lehofer M, Marksteiner J, Musalek M, Psota G, Rados C, Rittmannsberger H, Schubert H, Stupp\u00e4ck C, Uhlenhuth R, Wancata J, Windhager E, Z\u00f6chling R (2011) Experten-Statement: Stellenwert von Quetiapin XR (Seroquel XR) in der Behandlung der Major Depression. (Update Europe) Internationale Zeitschrift f\u00fcr \u00e4rztliche Fortbildung<\/em> 16 (ISSN 1726-0027) (IF:0)<\/p>\n

Kasper S, Kapfhammer HP, Marksteiner J, Rainer M, Schubert H (2011) Experten-Statement: Stellenwert von Ziprasidon in der Kombinationstherapie bei Schizophrenie und affektiven Erkrankungen. (Update Europe) Internationale Zeitschrift f\u00fcr \u00e4rztliche Fortbildung<\/em> 18 (ISSN
1726-0027) (IF:0)<\/p>\n

Kasper S, Lentner S (Hrsg.) (2011) \u00d6sterreichische Konsensus-Dokumente \u2013 Psychopharmakologie. Sammelband der \u00d6GPB 2005-2011. CliniCum neuropsy (IF:0)<\/p>\n

Kasper S, Meshkat D, Kutzelnigg A (2011) Improvement of the noradrenergie symptom cluster
following treatment with milnacipran. Neuropsychiatric Disease and Treatment<\/em><\/a> 7 (Suppl. 1): 21-
27 (IF: 0)<\/p>\n

Kasper S, M\u00f6ller HJ (2011) Psychopharmakotherapie: klinisch-empirische Grundlagen. In: M\u00f6ller HJ, Laux G, Kapfhammer HP (Hrsg.) Psychiatrie und Psychotherapie<\/em>. 4. Auflage. Heidelberg: Springer, pp. 731-766<\/p>\n

Kasper S, Psota G, Geretsegger C, Kastner A, Naderi-Heiden A, Sachs GM, Walter E, Wolf W, Fruhw\u00fcrth G, Haring C, Kapfhammer HP, Lehofer M, Marksteiner J, Oberlerchner H, Praschak-Rieder N, Stetter R, Strnad A (2011) Depot-Antipsychotika\/-Neuroleptika. Konsensus-Statement – State of the art 2011. CliniCum neuropsy Sonderausgabe November 2011 (IF:0)
Kasper S, Rittmannsberger H, M\u00fcllner M (2011) \u00dcber Wirkung und unerw\u00fcnschte Wirkungen.
Psychiatrie & Psychotherapie<\/em> 3: 110-112 (IF: 0)<\/p>\n

Kasper S, Scheiner A, Geretsegger C, Hofmann P, Kalousek M, Kastner A, Lehofer M, Marksteiner J, Psota G, Rittmannsberger H, Wancata J (2011) Paliperidon-Palmitat. Expertise. <\/em>CliniCum neuropsy<\/em> Sonderausgabe<\/a> Oktober 2011 (IF:0)<\/p>\n

Kasper S, Vrabl J, Bach M, Kubelka W, Lalouschek W (2011) Expertenstatement: Stresssymptome wirksam behandeln: Vitango – Therapieinnovation durch die Kraft der Rosenwurz. scienceDIALOGUE<\/em><\/a> M\u00e4rz 2011 (IF: 0)<\/p>\n

Kaufmann R, Stompe T (2011) Medikament\u00f6se Behandlung von St\u00f6rungen der sexuellen Pr\u00e4ferenz. JATROS Neurologie & Psychiatrie<\/a><\/em> 7: 43-44 (IF: 0)<\/p>\n

Kaye WH, Bailer UF (2011) Understanding the neural circuitry of appetitive regulation in eating disorders. Biological Psychiatry<\/a><\/em> 70 (8): 704-705 (IF: 8.674)<\/p>\n

Kindler J, Bailer U, De Zwaan M, Fuchs K, Leisch F, Gr\u00fcn B, Strnad A, Stojanovic M, Windisch J, Lennk-Wolfsberg C, El-Giamal N, Sieghart W, Kasper S, Aschauer H (2011) No association of the neuropeptide Y (Leu7Pro) and ghrelin gene (Arg51Gln, Leu72Met, Gln90Leu) single nucleotide polymorphisms with eating disorders. Nordic Journal of Psychiatry<\/em><\/a> 65 (3): 203-207 (IF: 0.880)<\/p>\n

Klug S, Anderer P, Saletu-Zyhlarz G, Freidl M, Saletu B, Prause W, Aigner M (2011) Dysfunctional pain modulation in somatoform pain disorder patients. European Archives of<\/em> Psychiatry and Clinical Neuroscience<\/em> 261 (4): 267-275 (IF: 3.637)<\/p>\n

Kocabas NA, Faghel C, Barreto M, Kasper S, Linotte S, Mendlewicz J, Noro M, Oswald P,
Souery D, Zohar J, Massat I (2011) Brain-derived neurotrophic factid (BDNF) gene
polymorphisms: influence on treatment response phenotypes in major depressive disorder.
International Clinical Psychopharmacology<\/em> 26 (1): 1-10 (IF: 2.762)<\/p>\n

Konstantinidis A, Friedrich ME, Freidl M, Kasper S (2011) Faktor Gewichtszunahme. CliniCum<\/em>
neuropsy<\/em> 1: 18-19 (IF: 0)<\/p>\n

Konstantinidis A, Martiny K, Bech P, Kasper S (2011) A comparison of the Major Depression
Inventory (MDI) and the Beck Depression Inventory (BDI) in severely depressed patients.
International Journal of Psychiatry in Clinical Practice<\/em> 15 (1): 56-61 (IF: 0.327)<\/p>\n

Lanzenberger R, Kasper S (Gast-Editoren) (2011) Angsterkrankungen. Journal f\u00fcr Neurologie,<\/em>
Neurochirurgie und Psychiatrie<\/em> 12 (4): 331-359 (IF:0)<\/p>\n

Lanzenberger R, Kasper S (2011) Editorial \u201eAngsterkrankungen“. Journal f\u00fcr Neurologie,<\/em> Neurochirurgie und Psychiatrie<\/em> 12 (4): 331 (IF: 0)<\/p>\n

Lanzenberger R, Mitterhauser M, Kranz GS, Spindelegger C, Wadsak W, Stein P, Moser U, Savli M, Kletter K, Kasper S (2011) Progesterone level predicts serotonin-1A receptor binding in the male human brain. Neuroendocrinology<\/em> 94 (1): 84-88 (IF: 3.272)<\/p>\n

Lechner C, unter der Mitarbeit von Kasper S (2011) Internationale Spitzenforschung. Universit\u00e4tsklinik f\u00fcr Psychiatrie und Psychotherapie, Wien. CliniCum neuropsy 5: 10-11 (IF: 0)<\/p>\n

Lehofer M, Glehr R, Haring C, Jimenez P, Kasper S, Lalouschek W, Marksteiner J, Musalek M,
Sperner-Unterweger B, Titscher G, Weiss E (2011) Experten-Statement: Burn-out & Depression. Ein Leitfaden zur Pr\u00e4vention, Fr\u00fcherkennung und Behandlung. (Update Europe) Internationale<\/em>
Zeitschrift f\u00fcr \u00e4rztliche Fortbildung<\/em> 9 (ISSN 1726-0027) (IF:0)<\/p>\n

Lehrner, J, Stolba K, Traun-Vogt G, V\u00f6lkl Kernstock S (Hrsg.) (2011) Klinische Psychologie im<\/em> Krankenhaus<\/em>. Wien: Springer<\/p>\n

Lentner S, Kapfhammer HP, Kasper S, Bach M, Wrobel M, Rainer M, Marksteiner J, Psota G
(2011) Austrian Society of Neuropsychopharmacology and Biological Psychiatry, \u00d6sterreichische Gesellschaft f\u00fcr Neuropsychopharmakologie und Biologische Psychiatrie<\/em> (\u00d6GPB) Activities Report 1998-2011<\/em>. Medizin Medien Austria<\/p>\n

Maieron A, Metz-Gercek S, Scherzer TM, Laferl H, Fischer G, Bischof M, Gschwantler M,
Ferenci P (2011) Shortening of treatment duration in patients with chronic hepatitis C genotype 2
and 3 \u2013 impact of ribavirin dose \u2013 a randomized multicentre trial. BMC Research Notes<\/em> 4: 220
(IF: 0)<\/p>\n

Massat I, Kocabas NA, Crisafulli C, Chiesa A, Calati R, Linotte S, Kasper S, Fink M, Antonijevic I, Forray C, Snyder L, Bollen J, Zohar J, De Ronchi D, Souery D, Serretti A, Mendlewicz J (2011) COMT and age set at onset in mood disorders: a replication and extension study. Neuroscience Letters<\/em> 498 (3): 218-221 (IF: 2.055)<\/p>\n

Meshkat D, Kutzelnigg A, Eckert C, Konstantinidis A, Kasper S (2011) ADHS und affektive St\u00f6rungen. Selten diagnostiziert und behandelt. CliniCum neuropsy 3: 16-19 (IF: 0) Meshkat D, Kutzelnigg A, Winkler D, Kasper S (2011) Depression und Demenz. CliniCum<\/em> neuropsy<\/em> 6: 30-32 (IF: 0)<\/p>\n

Montgomery S, Hansen T, Kasper S (2011) Efficacy of escitalopram compared to citalopram: a
meta-analysis. International Journal of Neuropsychopharmacology 14 (2): 261-268 (IF: 4.699) Moser U, Lanzenberger R, Savli M, Kasper S (2011) Tiefe Hirnstimulation bei neuropsychiatrischen Erkrankungen: Status quo und Zukunftsperspektiven. CliniCum neuropsy<\/em> 1: 22-24 (IF: 0)<\/p>\n

M\u00fcller-Vahl KR, Cath DC, Cavanna AE, Dehning S, Porta M, Robertson MM, Visser-Vanderwalle V on behalf of the ESSTS Guidelines Group (Androutsos C, Aschauer H, Baird G, Bos-Veneman N, Bramilla A, Cardona F, Cath DC, Cavanna A, Czernecki V, Dehing S, Eapter A, Farkas L, Gadaros J, Hartmann A, Hauser E, Hedderly T, Heyman I, Hoekstra PJ, Korsgaard A, Jackson GM, Larsson L, Ludolph AG, Martino D, Menghetti C, Mol Debes N, Muller N, Muller-Vahl K, Munchau A, Murphy T, Musil R, Nagy P, Nurnberger J, Oostra B, Paschou P, Pasquini M, Plessen KJ, Porta M, Rickards H, Rizzo R, Robertson MM, Roessner V, Rothenberger A, Servello D, Skov L, Stern JS, Strand G, Tarnok Z, Termine C, Van der Griendt J, Verdellen C, Visser-Vanderwalle V, Wannag E, Wolanczyck T) (2011) European clinical guidelines for Tourette syndrome and other tic disorders. Part IV: deep brain stimulation. European Child & Adolescent Psychiatry<\/em> 20 (4): 209-217 (IF: 1.622)<\/p>\n

Olajossy-Hilkesberger L, Godlewska B, Schosser-Haupt A, Olajossy M, Wojcierowski J, Landowski J, Marmurowska-Michalowska H, Kasper S (2011) Polymorphisms of the 5-HT2A receptor gene and clinical response to olanzapine in paranoid schizophrenia. Neuropsychobiology<\/em> 64 (4): 202-210 (IF: 2.567)<\/p>\n

Olajossy-Hilkesberger Luiza, Olajossy Marcin (2011) The bipolar disorder over-diagnosis trend – in brief. (O nadrozpoznawalno\u015b ci zaburzenia afektywnego dwubiegunowego – rzecz kr\u00f3tka.) Current Problems in Psychiatry<\/em> 12 (3): 245-247 (IF: 0)<\/p>\n

Painold A, Anderer P, Holl AK, Letmaier M, Saletu-Zyhlarz GM, Saletu B, Bonelli RM (2011) EEG low-resolution brain electromagnetic tomography (LORETA) in Huntington’s disease. Journal of Neurology<\/em> 258 (5): 840-854 (IF: 3.853) Pail G, Huf W, Pjrek E, Winkler D, Willeit M, Praschak Rieder N, Kasper S (2011) Bright light therapy in the treatment of mood disorders. Neuropsychobiology 64 (3): 152-162 (IF: 2.567) Papageorgiou K, Konstantinidis A, Fink M, Frey R, Kasper S (2011) Restless Legs Syndrom unter Psychopharmaka. CliniCum neuropsy<\/em> 3: 24-25 (IF: 0)<\/p>\n

Praschak-Rieder N (2011) Lichttherapie. In: Gr\u00fcnder G, Benkert O (Hrsg.) Handbuch der<\/em> psychiatrischen Pharmakotherapie<\/em>. Wien: Springer, pp 823-827<\/p>\n

Rabl U, Scharinger C, Hofmaier T, Freissmuth M, Pezawas L (2011) Genetic regulation of emotion brain circuitries. In: L\u00f3pez-Mu\u00f1oz F \u00c1C (ed.) Neurobiology of Depression<\/em>. Boca Raton: CRC Press, pp. 75-95<\/p>\n

Roessner V, Plessen KJ, Rothenberger A, Ludolph AG, Rizzo R, Skov L, Strand G, Stern JS, Termine C, Hoekstra PJ on behalf of the ESSTS Guidelines Group (Androutsos C, Aschauer H,
Baird G, Bos-Veneman N, Bramilla A, Cardona F, Cath DC, Cavanna A, Czernecki V, Dehing
S, Eapter A, Farkas L, Gadaros J, Hartmann A, Hauser E, Hedderly T, Heyman I, Hoekstra PJ,
Korsgaard A, Jackson GM, Larsson L, Ludolph AG, Martino D, Menghetti C, Mol Debes N, Muller N, Muller-Vahl K, Munchau A, Murphy T, Musil R, Nagy P, Nurnberger J, Oostra B, Paschou P, Pasquini M, Plessen KJ, Porta M, Rickards H, Rizzo R, Robertson MM, Roessner V, Rothenberger A, Servello D, Skov L, Stern JS, Strand G, Tarnok Z, Termine C, Van der Griendt J, Verdellen C, Visser Vanderwalle V, Wannag E, Wolanczyck T) (2011) European clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological treatment.European Child & Adolescent Psychiatry<\/em> 20 (4): 173-196 (IF: 1.622)<\/p>\n

Saletu B, Anderer P, Saletu-Zyhlarz GM (2011) Schlafst\u00f6rungen im Alter. Von der Schlafhygiene bis zur differenzierten Therapie. \u00d6sterreichische Apothekerzeitung<\/em> 65 (6): 33-35 (IF: 0)<\/p>\n

Scharinger C, Bartova L, Pezawas L (2011) Brain-derived neurotrophic factor: a peripheral biomarker for major depressive disorder and antidepressant efficacy? Personalized Medicine<\/em> 8
(2): 115-117 (IF: 0.783)<\/p>\n

Scharinger C, Rabl U, Pezawas L, Kasper S (2011) The genetic blueprint of major depressive disorder: contributions of imaging genetics studies. World Journal of Biological Psychiatry<\/em> 12
(7): 474-88 (IF: 2.048) Sch\u00f6pf V, Windischberger C, Robinson S, Kasess C, Fischmeister F, Lanzenberger R, Albrecht J, Kleemann A, Kopietz R, Wiesmann M, Moser E. (2011) Model-free fMRI group analysis using FENICA. NeuroImage 55<\/em>(1): 185-93 (IF: 5.937)<\/p>\n

Schosser A, Butler AW, Ising M, Perroud N, Uher R, Ng MY, Cohen-Woods S, Craddock N, Owen MJ, Korszun A, Jones L, Jones I, Gill M, Rice JP, Maier W, Mors O, Rietschel M, Lucae S, Binder EB, Preisig M, Perry J, Tozzi F, Muglia P, Aitchison KJ, Breen G, Craig IW, Farmer AE, M\u00fcller-Myhsok B, McGuffin P, Lewis CM (2011) Genomewide association scan of suicidal thoughts and behaviour in major depression. PLoS One<\/em> 6 (7): e20690 (IF: 4.411)<\/p>\n

Schosser A, Gaysina D, Cohen-Woods S, Domenici E, Perry J, Tozzi F, Korszun A, Gunasinghe C, Gray J, Jones L, Binder EB, Holsboer F, Craddock N, Owen MJ, Craig IW, Farmer AE, Muglia P, McGuffin P (2011) A follow-up case-control association study of tractable (druggable) genes in recurrent major depression. American Journal of Medical Genetics Part B<\/em> Neuropsychiatric Genetics<\/em> 156 (B): 640-650 (IF: 4.156)<\/p>\n

Schosser A, Schl\u00f6gelhofer M, Fuchs K, Stojanovic M, Mossaheb N, Kindler J, Cohen-Woods S, Hosang G, Farmer A, Craig I, McGuffin P, Aschauer H (2011) Bipolar disorder susceptibility region on chromosome 3q29 not confirmed in a case-control association study. The World<\/em> Journal of Biological Psychiatry<\/em> 12 (4): 309-15 (IF: 2.048)<\/p>\n

Serretti A, Chiesa A, Calati R, Massat I, Linotte S, Kasper S, Lecrubier Y, Antonijevic I, Forray C, Snyder L, Bollen J, Zohar J, De Ronchi D, Souery D, Mendlewicz J (2011) A preliminary investigation of the influence of CREB1 gene on treatment resistance in major depression. Journal of Affective Disorders<\/em> 128 (1-2): 56-63 (IF: 3.740)<\/p>\n

Serretti A, Chiesa A, Calati R, Massat I, Linotte S, Kasper S, Lecrubier Y, Fink M, Antonijevic I, Forray C, Snyder L, Bollen J, Zohar J, De Ronchi D, Souery D, Mendlewicz J (2011) No influence of PTGS2 polymorphisms on response and remission to antidepressants in major depression. Psychiatry Research<\/em> 188 (1): 166-169 (IF: 2.803)<\/p>\n

Souery D, Serretti A, Calati R, Oswald P, Massat I, Konstantinidis A, Linotte S, Bollen J, Demyttenaere K, Kasper S, Lecrubier Y, Montgomery S, Zohar J, Mendlewicz J (2011) Switching antidepressant class does not improve response or remission in treatment-resistant depression. Journal of Clinical Psychopharmacology<\/em> 31 (4): 512-516 (IF: 4.857)<\/p>\n

Souery D, Serretti A, Calati R, Oswald P, Massat I, Konstantinidis A, Linotte S, Kasper S, Montgomery S, Zohar J, Mendlewicz J (2011) Citalopram versus desipramine in treatment resistant depression: effect of continuation or switching strategies. A randomized open study. World Journal of Biological Psychiatry<\/em> 12 (5): 364-375 (IF: 2.048)<\/p>\n

Souery D, Zaninotto L, Calati R, Linotte S, Sentissi O, Amital D, Moser U, Kasper S, Zohar J, Mendlewicz J, Serretti A (2011) Phenomenology of psychotic mood disorders: lifetime and major depressive episode features. Journal of Affective Disorders<\/em> 135 (1-3): 241-50 (IF: 3.740)<\/p>\n

Soyka M, Kranzler HR, van den Brink W, Krystal K, M\u00f6ller HJ, Kasper S and the WFSBP task
force on treatment, guidelines for substance use disorders (2011) The World Federation of
Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of substance
use and related disorders. Part 2: Opioi<\/p>\n

Liste der Publikationen 2011<\/strong><\/h2>\n

 <\/p>\n

[\/et_pb_text][et_pb_button button_text=“PDF downloaden“ _builder_version=“4.9.4″ _module_preset=“a3073b5a-5137-4325-b0e5-961f161334ae“ button_url=“https:\/\/oegpb.at\/wp-content\/uploads\/2014\/06\/publikation2011.pdf“ url_new_window=“on“ hover_enabled=“0″ sticky_enabled=“0″][\/et_pb_button][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"

[et_pb_section fb_built=“1″ _builder_version=“4.9.4″ _module_preset=“a101c382-f6f4-4378-9eee-5c6c65b689e1″ locked=“off“][et_pb_row _builder_version=“4.9.3″ _module_preset=“default“ custom_padding=“||10px||false|false“][et_pb_column type=“4_4″ _builder_version=“4.9.3″ _module_preset=“default“][et_pb_post_title _builder_version=“4.9.3″ _module_preset=“7fd05a31-4b65-4680-8d87-3be606eca9dc“][\/et_pb_post_title][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=“1″ admin_label=“section“ _builder_version=“3.22″][et_pb_row admin_label=“row“ _builder_version=“4.9.4″ background_size=“initial“ background_position=“top_left“ background_repeat=“repeat“ box_shadow_style=“preset1″ custom_padding=“40px|40px|40px|40px|true|true“ custom_padding_last_edited=“on|phone“ hover_enabled=“0″ sticky_enabled=“0″ custom_padding_phone=“|20px||20px|true|true“][et_pb_column type=“4_4″ _builder_version=“3.25″ custom_padding=“|||“ custom_padding__hover=“|||“][et_pb_text admin_label=“Text“ _builder_version=“3.27.4″ background_size=“initial“ background_position=“top_left“ background_repeat=“repeat“] Ausgew\u00e4hlte Publikationen f\u00fcr das Jahr 2011 Aktuelle Forschungsarbeiten der Klinischen Abteilung f\u00fcr Biologische Psychiatrie, Universit\u00e4tsklinik f\u00fcr Psychiatrie und Psychotherapie, […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":97,"menu_order":0,"comment_status":"open","ping_status":"open","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"\n\t\t\t\t

Ausgew\u00e4hlte Publikationen f\u00fcr das Jahr 2011<\/h2>\n\nAktuelle Forschungsarbeiten der Klinischen Abteilung f\u00fcr Biologische Psychiatrie, Universit\u00e4tsklinik f\u00fcr Psychiatrie und Psychotherapie, Wien, Abteilungsvorstand:<\/strong>\nO. Univ. Prof. Dr.h.c.mult. Dr.med. Siegfried Kasper:\nsci-biolpsy@meduniwien.ac.at<\/a>\n\n

<\/a>Publikationen 2011<\/h2>\n\nAbbate Daga G, Gramaglia C, Bailer U, Bergese S, Marzola E, Fassino S (2011) Major Depression and Avoidant Personality Traits in Eating Disorders. Psychotherapy and<\/em><\/a> Psychosomatics<\/em><\/a> 80 (5): 319-320 (IF: 6.000)\n\nAcel A, Jank R, Schranz S, Zielinski C (2011) Klinische Psychologie in der Inneren Medizin I \u2013 Klinisch psychologische Betreuung von ambulanten und station\u00e4ren PatientInnen bei malignen Erkrankungen. In: Lehrner J, Stolba K, Traun-Vogt G, V\u00f6lkl-Kernstock S (Hrsg.) Klinische<\/a> Psychologie im Krankenhaus<\/a>. Wien: Springer, pp. 203-211\n\nAigner M, Treasure J, Kaye W, Kasper S and the WFSBP task force on eating disorders (2011) The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of eating disorders. World Journal of Biological Psychiatry<\/em> 12 (6):<\/a> 400-443 <\/a>(IF: 2.048)\n\nAschauer H (2011) Genetik und Epigenetik. In: L\u00f6ffler-Stastka H., Schuster P, und Doering S. (Hrsg.) Psychische Funktionen in Gesundheit und Krankheit.<\/a> 8., vollst. \u00fcberarb. Auflage. Wien: Facultas, pp 74-93\n\nBaghai TC, Blier P, Baldwin DS, Bauer M, Goodwin GM, Fountoulakis KN, Kasper S, Leonard BE, Malt UF, Stein DJ, Versiani M, M\u00f6ller HJ for the World Psychiatric Association (WPA) section of pharmacopsychiatry (2011) General and comparative efficacy and effectiveness of antidepressants in the acute treatment of depressive disorders: a report by the WPA section of pharmacopsychiatry. European Archives of Psychiatry and Clinical Neuroscience<\/em> 261 (Suppl.<\/a> 3): 207-245<\/a> (IF: 3.637)\n\nBailer UF, Bloss CS, Frank GK, Price JC, Meltzer CC, Mathis CA, Geyer MA, Wagner A, Becker CR, Schork NJ, Kaye WH (2011) 5-HT1A receptor binding is increased after recovery from bulimia nervosa compared to control women and is associated with behavioral inhibition in both groups. International Journal of Eating Disorders<\/em><\/a> 44 (6): 477- 487 (IF: 2.278)\n\nBailer UF, Kaye WH (2011) Serotonin \u2013 imaging findings in eating disorders. Current Topics in<\/em><\/a> Behavioral Neurosciences<\/em><\/a> 6: 59-79 (IF: 0)\n\nBauer S, Schanda H, Karakula H, Olajossy-Hilkesberger L, Rudaleviciene P, Okribelashvili N, Chaudhry H, Idemudia S, Gscheider S, Ritter K, Stompe T (2011) Culture and the prevalence of hallucinations in schizophrenia. Comprehensive Psychiatry<\/em><\/a> 52 (3): 319-325 (IF: 2.377)\n\nBauer SM, Steiner H, Feucht M, Stompe T, Karnik NS, Kasper S, Plattner B (2011) Psychosocial background in incarcerated adolescents from Austria, Turkey and former Yugoslavia. Psychiatry Research<\/em><\/a> 185 (1-2): 193-199 ( IF: 2.803)\n\nBokkon I, Till A, Grass F, Erd\u00f6fi Szabo A (2011) Phantom pain reduction by low-frequency and low-intensity electromagnetic fields. Electromagnetic Biology and Medicine<\/em><\/a> 30 (3): 115-27 (IF:\n1.041)\n\nBruckm\u00fcller K, K\u00f6chl B, Fischer G, Jagsch R, Soyer R (2011) Medizinische und juristische Beurteilung substanzabh\u00e4ngiger (mutma\u00dflicher) T\u00e4ter. Journal f\u00fcr Rechtspolitik<\/em><\/a> 19 (3): 267-278\n(IF: 0)\n\nCath DC, Hedderly T, Ludolph AG, Stern JS, Murphy T, Hartmann A, Czernecki V, Robertson MM, Martino D, Munchau A, Rizzo R on behalf of the ESSTS Guidelines Group (Androutsos C, Aschauer H, Baird G, Bos-Veneman N, Bramilla A, Cardona F, Cath DC, Cavanna A, Czernecki V, Dehing S, Eapter A, Farkas L, Gadaros J, Hartmann A, Hauser E, Hedderly T, Heyman I, Hoekstra PJ, Korsgaard A, Jackson GM, Larsson L, Ludolph AG, Martino D, Menghetti C, Mol Debes N, Muller N, Muller-Vahl K, Munchau A, Murphy T, Musil R, Nagy P, Nurnberger J, Oostra B, Paschou P, Pasquini M, Plessen KJ, Porta M, Rickards H, Rizzo R, Robertson MM, Roessner V, Rothenberger A, Servello D, Skov L, Stern JS, Strand G, Tarnok Z, Termine C, Van der Griendt J, Verdellen C, Visser Vanderwalle V, Wannag E, Wolanczyck T) (2011) European clinical guidelines for Tourette Syndrome and other tic disorders. Part I: assessment. European<\/em> Child & Adolescent Psychiatry<\/em><\/a> 20 (7): 155-171 (IF: 1.622)\n\nDiaconescu AO, Jensen J, Wang H, Willeit M, Menon M, Kapur S, McIntosh AR (2011)\nAberrant Effective Connectivity in Schizophrenia Patients During Appetitive Conditioning.\nFrontiers in Human Neuroscience<\/em><\/a> 4: 239 (IF: 1.940)\n\nDold M, Aigner M, Lanzenberger R, Kasper S (2011) Effektivit\u00e4t einer Augmentationstherapie mit Antipsychotika bei therapieresistenten Zwangsst\u00f6rungen - eine Meta-Analyse doppelblinder,\nrandomisierter, plazebokontrollierter Studien. Fortschritte Neurologie Psychiatrie<\/em><\/a> 79 (8): 453- 466 (IF: 0.652)\n\nFink M, Moser U, Akimova E, Savli M, Lanzenberger R, Kasper S (2011) Multimodale Bildgebung bei einer organischen depressiven St\u00f6rung mittels fMRT und PET. Journal f\u00fcr Neurologie, Neurochirurgie und Psychiatrie<\/em><\/a> 12 (2): 180-182 (IF: 0)\n\nFischer G (2011) Gerechtigkeit \u2013 Gl\u00fcck\/Gl\u00fccksspiel \u2013 Pathologisches Gl\u00fccksspiel. Sucht<\/em><\/a> 57 (4): 1-2 (IF: 0)\n\nFischer P, Winkler D (2011) Demenz aus Sicht der Psychiatrie. In: Maier M, H\u00f6rhan J (Hrsg). Arzt\/\u00c4rztin & Ethik<\/em>. 5. Auflage. Wien: Facultas, pp. 282-287\n\nFischer-Kern M, Kapusta N, Doering S, Hoerz S, Mikutta C, Aigner M (2011) The Relationship between Personality Organization and Psychiatric Classification in Chronic Pain Patients. Psychopathology<\/em><\/a> 44 (1): 21-26 (IF: 1.819)\n\nFrey R, Winkler D, Strnad A, Kasper S (2011) An der Schnittstelle zur Organmedizin.\nPsychiatrische Intensivstation. CliniCum neuropsy<\/em><\/a> 3: 20-23 (IF: 0)\n\nFriedrich ME, Kasper S (2011) Das metabolische Syndrom - Stellenwert in der Psychiatrie. CliniCum neuropsy<\/a> 1<\/em>: 14-16 (IF: 0)\n\nHahn A, Stein P, Windischberger C, Weissenbacher A, Spindelegger C, Moser E, Kasper S, Lanzenberger R (2011) Reduced resting-state functional connectivity between amygdala and\norbitofrontal cortex in social anxiety disorder. NeuroImage<\/em><\/a> 56 (3): 881-889 (IF: 5.937)\n\nHeil S, Jones H, Arria A, Kaltenbach K, Thomas J, Fischer G, Stine S, Selby P, Martin P (2011)\nUnintended pregnancy in opioid-abusing women. Journal of Substance Abuse Treatment<\/a><\/em> 40 (2):\n199-202 (IF: 2.805)\n\nH\u00f6fer P, Syeda B, Bergler-Klein J, Friedrich F, Lesch O, Vyssoki B, Binder T, Walter H (2011) Amino-Terminal Pro-B-Type Brain Natriuretic Peptide: Screening for Cardiovascular Disease in the Setting of Alcoholism. Alcohol and Alcoholism<\/em><\/a> 46 (3): 247- 252 (IF: 2.599)\n\nHolzer D, Stompe T (2011) Mord und Totschlag - Zusammenhang zwischen T\u00f6tungsdelikten und Kultur. \u00c4rzte Woche<\/a> 3: 11-12 (IF: 0)\n\nHolzer D, Stompe T (2011) Transkulturelle Psychiatrie: Pr\u00e4valenz psychischer Erkrankungen bei Migranten. <\/em>Spectrum Psychiatrie<\/em><\/a> 1: 39-42 (IF: 0)\n\nHuf W, Kalcher K, Kasper S (2011) Widespread methodological problems limit validity of\nmetaanalytic results. Psychotherapy and Psychosomatics<\/em><\/a> 80 (4): 246 (IF: 6.000)\n\nHuf W, Kalcher K, Pail G, Friedrich ME, Filzmoser P, Kasper S (2011) Metaanalysis: fact or fiction? How to interpret metaanalyses. World Journal of Biological Psychiatry<\/em><\/a> 12 (3): 188-200\n(IF: 2.048)\n\nInada Y, Nagata T, Kasper S (2011) \u30d1\u30cd\u30eb\u30c7\u30a3\u30b9\u30ab\u30c3\u30b7\u30e7\u30f3 (Proceedings of paneldiscussion). Published in Japanese language. CNS Drugs<\/em> 25 (Special Issue 1): 14-16 (IF:\n4.497)\n\nKapusta N, Aschauer H (2011) Psychopharmakotherapie. In: L\u00f6ffler-Stastka H., Schuster P, und\nDoering S. (Hrsg.) Psychische Funktionen in Gesundheit und Krankheit<\/em>. 8., vollst. \u00fcberarb.\nAuflage. Wien: Facultas, pp 306-311\n\nKapusta N, Mossaheb N, Etzersdorfer E, Hlavin G, Thau K, Willeit M, Praschak-Rieder N, Sonneck G, Leithner-Dziubas K (2011) Lithium in drinking water and suicide mortality. British<\/em> Journal of Psychiatry<\/em><\/a> 198 (5): 346-350 (IF: 5.947)\n\nKasper S (2011) Die verschiedenen Facetten des Ansprechens auf einen antidepressive Therapie und deren praktische Bedeutung. Journal f\u00fcr Neurologie, Neurochirurgie und Psychiatrie<\/em><\/a> 12 (2): 116-117 (IF: 0)\n\nKasper S (2011) From single depressive episode to depressive disorder: what are the risk factors? Medicographia<\/em><\/a> 33 (2): 187-194 (IF: 0)\n\nKasper S (2011) Kann man Gef\u00fchle sichtbar machen? Die Seele weint mit dem Gehirn. In: van Heyster P, Klammer B, Pycha R, Schwitzer J (Hrsg.) Die verborgene Kraft des Glaubens<\/em>.\nBrixen: Provinz Verlag<\/a>, pp. 27-31\n\nKasper S (2011) Prof. Dr. med. Dr. h.c. mult. Hans-J\u00fcrgen M\u00f6ller in der Medizin. Medizin +<\/em> Kunst<\/em> 23 (4): 8-12 (IF: 0)\n\nKasper S (2011) Psychiatrie \u2013 quo vadis? CliniCum neuropsy<\/em><\/a> 5: 6-8 (IF: 0)\n\nKasper S (2011) Unipolare Depression. CiniCum neuropsy<\/em><\/a> 5: 26-28 (IF: 0)\n\nKasper S (2011) \u6297\u3046\u3064\u85ac\u3092\u7528\u3044\u305f\u500b\u3005\u306e\u60a3\u8005\u306b\u5bfe\u3059\u308b\u6cbb\u7642: SSRI\/SNRI \u304a\u3088\u3073\u30df\u30eb\u30bf\u30b6 \u30d4\u30f3\u306b\u3064\u3044\u3066 (Individualized patient treatment with anti- depressants: focus on SSRIs\/SNRIs and mirtazapine). Published in Japanese language. CNS Drugs<\/em> 25 (Special Issue 1): 10-13 (IF:\n4.497)\n\nKasper S, Bach M, Fartacek R, Fruhw\u00fcrth G, Haring C, Hausmann A, Kapfhammer HP, Marksteiner J, Psota G, Rados C, Stupp\u00e4ck C (2011) Experten-Statement: Therapeutisches Spektrum von Duloxetin mit Schwerpunkt Major Depression - ein Update. (Update Europe<\/a>)\nInternationale Zeitschrift f\u00fcr \u00e4rztliche Fortbildung<\/em> 15 (ISSN 1726-0027) (IF: 0)\n\nKasper S, Bach M, Hausmann A, Hofmann P, Konstantinidis A, Lentner S, Psota G, Rainer M, Schosser-Haupt A, Spindelegger C, Wrobel M, Frey R, Geretsegger C, Haring C, Jelem H, Kapfhammer HP, Claudia Klier, Marksteiner J, Oberlerchner H, Praschak-Rieder N, Rados C, Windhager E, Winkler D (2011) Therapieresistente Depression. Klinik und Behandlungsoptionen. Konsensus-Statement - State of the art 2011<\/a>. CliniCum neuropsy<\/em>\nSonderausgabe November 2011 (IF: 0)\n\nKasper S, Baghai TC, Padberg F (2011) Sonstige biologische Therapieverfahren - Theoretische und empirische Grundlagen sowie klinische Anwendungsprinzipien. In: M\u00f6ller HJ, Laux G, Kapfhammer HP (Hrsg.) Psychiatrie und Psychotherapie<\/em><\/a>. 4. Auflage. Heidelberg: Springer, pp.\n767-805\n\nKasper S, Baldinger P, H\u00f6flich A, Lanzenberger R (2011) Die unipolare Depression richtig erkennen. Rasche Hilfe durch neue Therapieoptionen. Hausarzt<\/em> 7-8: 6-8 (IF: 0)\n\nKasper S, Gastpar M, M\u00fcller WE, Volz HP, M\u00f6ller HJ, Dienel A, Schl\u00e4fke S (2011)\nWirksamkeit und Vertr\u00e4glichkeit von Silexan, einer neuen, oral verabreichten Zubereitung aus Lavendel\u00f6l, bei subsyndromaler Angstst\u00f6rung - Evidenz aus klinischen Pr\u00fcfungen. Zeitschrift<\/em><\/a>\nf\u00fcr Phytotherapie<\/em><\/a> 32: 60-63 (IF: 0)\n\nKasper S, Haring C (2011) Ratgeber f\u00fcr Depression und Angstst\u00f6rungen (Patientenbrosch\u00fcre).\n(Update Europe) Internationale Zeitschrift f\u00fcr \u00c4rztliche Fortbildung<\/em>, pp. 1-18 (IF: 0)\n\nKasper S, Kalousek M, Kapfhammer HP, Aichhorn W, Butterfield-Meissl C, Fartacek R, Frey R, G\u00f6\u00dfler R, Haring C, Kapitany T, Kapusta N, Karwautz A, Klier C, Konstantinidis A, Leuteritz I, Marksteiner J, Musalek M, Niederkrotenthaler T, Praschak-Rieder N, Psota G, Rados C, Rainer M, Stein C, T\u00f6lk A, Wancata J, Windhager E (2011) Suizidalit\u00e4t. Konsensus-Statement - State of the art 2011. CliniCum neuropsy<\/em> Sonderausgabe<\/a> April 2011 (IF:0)\n\nKasper S, Kapfhammer HP, Bach M, Erfurth A, Haring C, Hausmann A, Hofmann P, Jelem H, Lehofer M, Marksteiner J, Musalek M, Psota G, Rados C, Rittmannsberger H, Schubert H, Stupp\u00e4ck C, Uhlenhuth R, Wancata J, Windhager E, Z\u00f6chling R (2011) Experten-Statement: Stellenwert von Quetiapin XR (Seroquel XR) in der Behandlung der Major Depression. (Update Europe) Internationale Zeitschrift f\u00fcr \u00e4rztliche Fortbildung<\/em> 16 (ISSN 1726-0027) (IF:0)\n\nKasper S, Kapfhammer HP, Marksteiner J, Rainer M, Schubert H (2011) Experten-Statement: Stellenwert von Ziprasidon in der Kombinationstherapie bei Schizophrenie und affektiven Erkrankungen. (Update Europe) Internationale Zeitschrift f\u00fcr \u00e4rztliche Fortbildung<\/em> 18 (ISSN\n1726-0027) (IF:0)\n\nKasper S, Lentner S (Hrsg.) (2011) \u00d6sterreichische Konsensus-Dokumente \u2013 Psychopharmakologie. Sammelband der \u00d6GPB 2005-2011. CliniCum neuropsy (IF:0)\n\nKasper S, Meshkat D, Kutzelnigg A (2011) Improvement of the noradrenergie symptom cluster\nfollowing treatment with milnacipran. Neuropsychiatric Disease and Treatment<\/em><\/a> 7 (Suppl. 1): 21-\n27 (IF: 0)\n\nKasper S, M\u00f6ller HJ (2011) Psychopharmakotherapie: klinisch-empirische Grundlagen. In: M\u00f6ller HJ, Laux G, Kapfhammer HP (Hrsg.) Psychiatrie und Psychotherapie<\/em>. 4. Auflage. Heidelberg: Springer, pp. 731-766\n\nKasper S, Psota G, Geretsegger C, Kastner A, Naderi-Heiden A, Sachs GM, Walter E, Wolf W, Fruhw\u00fcrth G, Haring C, Kapfhammer HP, Lehofer M, Marksteiner J, Oberlerchner H, Praschak-Rieder N, Stetter R, Strnad A (2011) Depot-Antipsychotika\/-Neuroleptika. Konsensus-Statement - State of the art 2011. CliniCum neuropsy Sonderausgabe November 2011 (IF:0)\nKasper S, Rittmannsberger H, M\u00fcllner M (2011) \u00dcber Wirkung und unerw\u00fcnschte Wirkungen.\nPsychiatrie & Psychotherapie<\/em> 3: 110-112 (IF: 0)\n\nKasper S, Scheiner A, Geretsegger C, Hofmann P, Kalousek M, Kastner A, Lehofer M, Marksteiner J, Psota G, Rittmannsberger H, Wancata J (2011) Paliperidon-Palmitat. Expertise. <\/em>CliniCum neuropsy<\/em> Sonderausgabe<\/a> Oktober 2011 (IF:0)\n\nKasper S, Vrabl J, Bach M, Kubelka W, Lalouschek W (2011) Expertenstatement: Stresssymptome wirksam behandeln: Vitango - Therapieinnovation durch die Kraft der Rosenwurz. scienceDIALOGUE<\/em><\/a> M\u00e4rz 2011 (IF: 0)\n\nKaufmann R, Stompe T (2011) Medikament\u00f6se Behandlung von St\u00f6rungen der sexuellen Pr\u00e4ferenz. JATROS Neurologie & Psychiatrie<\/a><\/em> 7: 43-44 (IF: 0)\n\nKaye WH, Bailer UF (2011) Understanding the neural circuitry of appetitive regulation in eating disorders. Biological Psychiatry<\/a><\/em> 70 (8): 704-705 (IF: 8.674)\n\nKindler J, Bailer U, De Zwaan M, Fuchs K, Leisch F, Gr\u00fcn B, Strnad A, Stojanovic M, Windisch J, Lennk-Wolfsberg C, El-Giamal N, Sieghart W, Kasper S, Aschauer H (2011) No association of the neuropeptide Y (Leu7Pro) and ghrelin gene (Arg51Gln, Leu72Met, Gln90Leu) single nucleotide polymorphisms with eating disorders. Nordic Journal of Psychiatry<\/em><\/a> 65 (3): 203-207 (IF: 0.880)\n\nKlug S, Anderer P, Saletu-Zyhlarz G, Freidl M, Saletu B, Prause W, Aigner M (2011) Dysfunctional pain modulation in somatoform pain disorder patients. European Archives of<\/em> Psychiatry and Clinical Neuroscience<\/em> 261 (4): 267-275 (IF: 3.637)\n\nKocabas NA, Faghel C, Barreto M, Kasper S, Linotte S, Mendlewicz J, Noro M, Oswald P,\nSouery D, Zohar J, Massat I (2011) Brain-derived neurotrophic factid (BDNF) gene\npolymorphisms: influence on treatment response phenotypes in major depressive disorder.\nInternational Clinical Psychopharmacology<\/em> 26 (1): 1-10 (IF: 2.762)\n\nKonstantinidis A, Friedrich ME, Freidl M, Kasper S (2011) Faktor Gewichtszunahme. CliniCum<\/em>\nneuropsy<\/em> 1: 18-19 (IF: 0)\n\nKonstantinidis A, Martiny K, Bech P, Kasper S (2011) A comparison of the Major Depression\nInventory (MDI) and the Beck Depression Inventory (BDI) in severely depressed patients.\nInternational Journal of Psychiatry in Clinical Practice<\/em> 15 (1): 56-61 (IF: 0.327)\n\nLanzenberger R, Kasper S (Gast-Editoren) (2011) Angsterkrankungen. Journal f\u00fcr Neurologie,<\/em>\nNeurochirurgie und Psychiatrie<\/em> 12 (4): 331-359 (IF:0)\n\nLanzenberger R, Kasper S (2011) Editorial \u201eAngsterkrankungen\". Journal f\u00fcr Neurologie,<\/em> Neurochirurgie und Psychiatrie<\/em> 12 (4): 331 (IF: 0)\n\nLanzenberger R, Mitterhauser M, Kranz GS, Spindelegger C, Wadsak W, Stein P, Moser U, Savli M, Kletter K, Kasper S (2011) Progesterone level predicts serotonin-1A receptor binding in the male human brain. Neuroendocrinology<\/em> 94 (1): 84-88 (IF: 3.272)\n\nLechner C, unter der Mitarbeit von Kasper S (2011) Internationale Spitzenforschung. Universit\u00e4tsklinik f\u00fcr Psychiatrie und Psychotherapie, Wien. CliniCum neuropsy 5: 10-11 (IF: 0)\n\nLehofer M, Glehr R, Haring C, Jimenez P, Kasper S, Lalouschek W, Marksteiner J, Musalek M,\nSperner-Unterweger B, Titscher G, Weiss E (2011) Experten-Statement: Burn-out & Depression. Ein Leitfaden zur Pr\u00e4vention, Fr\u00fcherkennung und Behandlung. (Update Europe) Internationale<\/em>\nZeitschrift f\u00fcr \u00e4rztliche Fortbildung<\/em> 9 (ISSN 1726-0027) (IF:0)\n\nLehrner, J, Stolba K, Traun-Vogt G, V\u00f6lkl Kernstock S (Hrsg.) (2011) Klinische Psychologie im<\/em> Krankenhaus<\/em>. Wien: Springer\n\nLentner S, Kapfhammer HP, Kasper S, Bach M, Wrobel M, Rainer M, Marksteiner J, Psota G\n(2011) Austrian Society of Neuropsychopharmacology and Biological Psychiatry, \u00d6sterreichische Gesellschaft f\u00fcr Neuropsychopharmakologie und Biologische Psychiatrie<\/em> (\u00d6GPB) Activities Report 1998-2011<\/em>. Medizin Medien Austria\n\nMaieron A, Metz-Gercek S, Scherzer TM, Laferl H, Fischer G, Bischof M, Gschwantler M,\nFerenci P (2011) Shortening of treatment duration in patients with chronic hepatitis C genotype 2\nand 3 \u2013 impact of ribavirin dose \u2013 a randomized multicentre trial. BMC Research Notes<\/em> 4: 220\n(IF: 0)\n\nMassat I, Kocabas NA, Crisafulli C, Chiesa A, Calati R, Linotte S, Kasper S, Fink M, Antonijevic I, Forray C, Snyder L, Bollen J, Zohar J, De Ronchi D, Souery D, Serretti A, Mendlewicz J (2011) COMT and age set at onset in mood disorders: a replication and extension study. Neuroscience Letters<\/em> 498 (3): 218-221 (IF: 2.055)\n\nMeshkat D, Kutzelnigg A, Eckert C, Konstantinidis A, Kasper S (2011) ADHS und affektive St\u00f6rungen. Selten diagnostiziert und behandelt. CliniCum neuropsy 3: 16-19 (IF: 0) Meshkat D, Kutzelnigg A, Winkler D, Kasper S (2011) Depression und Demenz. CliniCum<\/em> neuropsy<\/em> 6: 30-32 (IF: 0)\n\nMontgomery S, Hansen T, Kasper S (2011) Efficacy of escitalopram compared to citalopram: a\nmeta-analysis. International Journal of Neuropsychopharmacology 14 (2): 261-268 (IF: 4.699) Moser U, Lanzenberger R, Savli M, Kasper S (2011) Tiefe Hirnstimulation bei neuropsychiatrischen Erkrankungen: Status quo und Zukunftsperspektiven. CliniCum neuropsy<\/em> 1: 22-24 (IF: 0)\n\nM\u00fcller-Vahl KR, Cath DC, Cavanna AE, Dehning S, Porta M, Robertson MM, Visser-Vanderwalle V on behalf of the ESSTS Guidelines Group (Androutsos C, Aschauer H, Baird G, Bos-Veneman N, Bramilla A, Cardona F, Cath DC, Cavanna A, Czernecki V, Dehing S, Eapter A, Farkas L, Gadaros J, Hartmann A, Hauser E, Hedderly T, Heyman I, Hoekstra PJ, Korsgaard A, Jackson GM, Larsson L, Ludolph AG, Martino D, Menghetti C, Mol Debes N, Muller N, Muller-Vahl K, Munchau A, Murphy T, Musil R, Nagy P, Nurnberger J, Oostra B, Paschou P, Pasquini M, Plessen KJ, Porta M, Rickards H, Rizzo R, Robertson MM, Roessner V, Rothenberger A, Servello D, Skov L, Stern JS, Strand G, Tarnok Z, Termine C, Van der Griendt J, Verdellen C, Visser-Vanderwalle V, Wannag E, Wolanczyck T) (2011) European clinical guidelines for Tourette syndrome and other tic disorders. Part IV: deep brain stimulation. European Child & Adolescent Psychiatry<\/em> 20 (4): 209-217 (IF: 1.622)\n\nOlajossy-Hilkesberger L, Godlewska B, Schosser-Haupt A, Olajossy M, Wojcierowski J, Landowski J, Marmurowska-Michalowska H, Kasper S (2011) Polymorphisms of the 5-HT2A receptor gene and clinical response to olanzapine in paranoid schizophrenia. Neuropsychobiology<\/em> 64 (4): 202-210 (IF: 2.567)\n\nOlajossy-Hilkesberger Luiza, Olajossy Marcin (2011) The bipolar disorder over-diagnosis trend - in brief. (O nadrozpoznawalno\u015b ci zaburzenia afektywnego dwubiegunowego - rzecz kr\u00f3tka.) Current Problems in Psychiatry<\/em> 12 (3): 245-247 (IF: 0)\n\nPainold A, Anderer P, Holl AK, Letmaier M, Saletu-Zyhlarz GM, Saletu B, Bonelli RM (2011) EEG low-resolution brain electromagnetic tomography (LORETA) in Huntington's disease. Journal of Neurology<\/em> 258 (5): 840-854 (IF: 3.853) Pail G, Huf W, Pjrek E, Winkler D, Willeit M, Praschak Rieder N, Kasper S (2011) Bright light therapy in the treatment of mood disorders. Neuropsychobiology 64 (3): 152-162 (IF: 2.567) Papageorgiou K, Konstantinidis A, Fink M, Frey R, Kasper S (2011) Restless Legs Syndrom unter Psychopharmaka. CliniCum neuropsy<\/em> 3: 24-25 (IF: 0)\n\nPraschak-Rieder N (2011) Lichttherapie. In: Gr\u00fcnder G, Benkert O (Hrsg.) Handbuch der<\/em> psychiatrischen Pharmakotherapie<\/em>. Wien: Springer, pp 823-827\n\nRabl U, Scharinger C, Hofmaier T, Freissmuth M, Pezawas L (2011) Genetic regulation of emotion brain circuitries. In: L\u00f3pez-Mu\u00f1oz F \u00c1C (ed.) Neurobiology of Depression<\/em>. Boca Raton: CRC Press, pp. 75-95\n\nRoessner V, Plessen KJ, Rothenberger A, Ludolph AG, Rizzo R, Skov L, Strand G, Stern JS, Termine C, Hoekstra PJ on behalf of the ESSTS Guidelines Group (Androutsos C, Aschauer H,\nBaird G, Bos-Veneman N, Bramilla A, Cardona F, Cath DC, Cavanna A, Czernecki V, Dehing\nS, Eapter A, Farkas L, Gadaros J, Hartmann A, Hauser E, Hedderly T, Heyman I, Hoekstra PJ,\nKorsgaard A, Jackson GM, Larsson L, Ludolph AG, Martino D, Menghetti C, Mol Debes N, Muller N, Muller-Vahl K, Munchau A, Murphy T, Musil R, Nagy P, Nurnberger J, Oostra B, Paschou P, Pasquini M, Plessen KJ, Porta M, Rickards H, Rizzo R, Robertson MM, Roessner V, Rothenberger A, Servello D, Skov L, Stern JS, Strand G, Tarnok Z, Termine C, Van der Griendt J, Verdellen C, Visser Vanderwalle V, Wannag E, Wolanczyck T) (2011) European clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological treatment.European Child & Adolescent Psychiatry<\/em> 20 (4): 173-196 (IF: 1.622)\n\nSaletu B, Anderer P, Saletu-Zyhlarz GM (2011) Schlafst\u00f6rungen im Alter. Von der Schlafhygiene bis zur differenzierten Therapie. \u00d6sterreichische Apothekerzeitung<\/em> 65 (6): 33-35 (IF: 0)\n\nScharinger C, Bartova L, Pezawas L (2011) Brain-derived neurotrophic factor: a peripheral biomarker for major depressive disorder and antidepressant efficacy? Personalized Medicine<\/em> 8\n(2): 115-117 (IF: 0.783)\n\nScharinger C, Rabl U, Pezawas L, Kasper S (2011) The genetic blueprint of major depressive disorder: contributions of imaging genetics studies. World Journal of Biological Psychiatry<\/em> 12\n(7): 474-88 (IF: 2.048) Sch\u00f6pf V, Windischberger C, Robinson S, Kasess C, Fischmeister F, Lanzenberger R, Albrecht J, Kleemann A, Kopietz R, Wiesmann M, Moser E. (2011) Model-free fMRI group analysis using FENICA. NeuroImage 55<\/em>(1): 185-93 (IF: 5.937)\n\nSchosser A, Butler AW, Ising M, Perroud N, Uher R, Ng MY, Cohen-Woods S, Craddock N, Owen MJ, Korszun A, Jones L, Jones I, Gill M, Rice JP, Maier W, Mors O, Rietschel M, Lucae S, Binder EB, Preisig M, Perry J, Tozzi F, Muglia P, Aitchison KJ, Breen G, Craig IW, Farmer AE, M\u00fcller-Myhsok B, McGuffin P, Lewis CM (2011) Genomewide association scan of suicidal thoughts and behaviour in major depression. PLoS One<\/em> 6 (7): e20690 (IF: 4.411)\n\nSchosser A, Gaysina D, Cohen-Woods S, Domenici E, Perry J, Tozzi F, Korszun A, Gunasinghe C, Gray J, Jones L, Binder EB, Holsboer F, Craddock N, Owen MJ, Craig IW, Farmer AE, Muglia P, McGuffin P (2011) A follow-up case-control association study of tractable (druggable) genes in recurrent major depression. American Journal of Medical Genetics Part B<\/em> Neuropsychiatric Genetics<\/em> 156 (B): 640-650 (IF: 4.156)\n\nSchosser A, Schl\u00f6gelhofer M, Fuchs K, Stojanovic M, Mossaheb N, Kindler J, Cohen-Woods S, Hosang G, Farmer A, Craig I, McGuffin P, Aschauer H (2011) Bipolar disorder susceptibility region on chromosome 3q29 not confirmed in a case-control association study. The World<\/em> Journal of Biological Psychiatry<\/em> 12 (4): 309-15 (IF: 2.048)\n\nSerretti A, Chiesa A, Calati R, Massat I, Linotte S, Kasper S, Lecrubier Y, Antonijevic I, Forray C, Snyder L, Bollen J, Zohar J, De Ronchi D, Souery D, Mendlewicz J (2011) A preliminary investigation of the influence of CREB1 gene on treatment resistance in major depression. Journal of Affective Disorders<\/em> 128 (1-2): 56-63 (IF: 3.740)\n\nSerretti A, Chiesa A, Calati R, Massat I, Linotte S, Kasper S, Lecrubier Y, Fink M, Antonijevic I, Forray C, Snyder L, Bollen J, Zohar J, De Ronchi D, Souery D, Mendlewicz J (2011) No influence of PTGS2 polymorphisms on response and remission to antidepressants in major depression. Psychiatry Research<\/em> 188 (1): 166-169 (IF: 2.803)\n\nSouery D, Serretti A, Calati R, Oswald P, Massat I, Konstantinidis A, Linotte S, Bollen J, Demyttenaere K, Kasper S, Lecrubier Y, Montgomery S, Zohar J, Mendlewicz J (2011) Switching antidepressant class does not improve response or remission in treatment-resistant depression. Journal of Clinical Psychopharmacology<\/em> 31 (4): 512-516 (IF: 4.857)\n\nSouery D, Serretti A, Calati R, Oswald P, Massat I, Konstantinidis A, Linotte S, Kasper S, Montgomery S, Zohar J, Mendlewicz J (2011) Citalopram versus desipramine in treatment resistant depression: effect of continuation or switching strategies. A randomized open study. World Journal of Biological Psychiatry<\/em> 12 (5): 364-375 (IF: 2.048)\n\nSouery D, Zaninotto L, Calati R, Linotte S, Sentissi O, Amital D, Moser U, Kasper S, Zohar J, Mendlewicz J, Serretti A (2011) Phenomenology of psychotic mood disorders: lifetime and major depressive episode features. Journal of Affective Disorders<\/em> 135 (1-3): 241-50 (IF: 3.740)\n\nSoyka M, Kranzler HR, van den Brink W, Krystal K, M\u00f6ller HJ, Kasper S and the WFSBP task\nforce on treatment, guidelines for substance use disorders (2011) The World Federation of\nSocieties of Biological Psychiatry (WFSBP) guidelines for the biological treatment of substance\nuse and related disorders. Part 2: Opioi\n\n

Liste der Publikationen 2011<\/strong><\/h2>\n\n>> PDF downloaden<\/a>\n\t\t","_et_gb_content_width":"","footnotes":""},"class_list":["post-323","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/oegpb.at\/index.php?rest_route=\/wp\/v2\/pages\/323","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/oegpb.at\/index.php?rest_route=\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/oegpb.at\/index.php?rest_route=\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/oegpb.at\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/oegpb.at\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=323"}],"version-history":[{"count":2,"href":"https:\/\/oegpb.at\/index.php?rest_route=\/wp\/v2\/pages\/323\/revisions"}],"predecessor-version":[{"id":5945,"href":"https:\/\/oegpb.at\/index.php?rest_route=\/wp\/v2\/pages\/323\/revisions\/5945"}],"up":[{"embeddable":true,"href":"https:\/\/oegpb.at\/index.php?rest_route=\/wp\/v2\/pages\/97"}],"wp:attachment":[{"href":"https:\/\/oegpb.at\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=323"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}